Skip to main content

Main navigation

Resources
Events
- Upcoming Events
- On-Demand Recordings
About

Newsletter sign-up

Main navigation

Resources
Events
- Upcoming Events
- On-Demand Recordings
About

Newsletter sign-up

Events

Browse upcoming clinical education events and explore on‑demand recordings from conferences and expert‑led sessions—all focused on real-world CGM use.

Image

presenter-at-podium

Breadcrumb

Home
Events

Search

BROWSE TOPICS

Billing & Reimbursement
Case Studies
CGM Basics
Clinic Training & Workflows
Conferences
Data Interpretation
Guidelines & Research
Patient Education
Product Training
Tools & Troubleshooting

Filter

Event Type

Past Event

Upcoming Event

Topic

Billing & Reimbursement

Case Studies

CGM Basics

Clinic Training & Workflows

Conferences

Data Interpretation

Guidelines & Research

Patient Education

Product Training

Tools & Troubleshooting

Clinical Focus

Hospital Discharge

Pediatrics

Prediabetes

Pregnancy

Type 1 Diabetes

Type 2 Diabetes

Veterans & Federal

Displaying 1–2 results out of 2

Upcoming Event April 22 – April 24, 2026

7:00 AM - 3:30 PM Las Vegas, Nevada

AACE Annual Meeting

Upcoming Event April 16 – April 18, 2026

7:00 AM - 6:30 PM San Francisco, CA

ACP Internal Medicine Meeting

Stay engaged

Sign up for our newsletter to stay up to date on new content and the latest developments in the industry.

Email Address

NPI Number

First Name

Last Name

Areas of Interest

Type 1 Diabetes

Type 2 Diabetes

Pregnancy

Pediatrics

Prediabetes

Pharmacy

Hospital Discharge

Veterans & Federal

GlucoseTech

Dexcom, headquartered in San Diego, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients.

Footer Left

Site Pages
Home
About GlucoseTech
Contact Us
Contributors

Footer Middle

Policies
Terms of Use
Privacy Policy
Cookie Policy
Safety Information

Footer Right

Dexcom Resources
Coverage & Affordability
Request a Product Sample
Connect with a Representative

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the
Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries

MAT-13418

Copyright © Dexcom, Inc. All rights reserved.